review of ingredients added to cigarettes overview kara lewis, ph.d. staff scientist

13
Review of Ingredients Added to Cigarettes Overview Kara Lewis, Ph.D. Staff Scientist

Upload: yin

Post on 21-Jan-2016

24 views

Category:

Documents


0 download

DESCRIPTION

Review of Ingredients Added to Cigarettes Overview Kara Lewis, Ph.D. Staff Scientist. Epidemiology shows that cigarette smoking associates with premature human mortality Effect of added ingredients is unknown. Introduction. A substance other than tobacco that is added to a cigarette. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Review of Ingredients Added to Cigarettes Overview Kara Lewis, Ph.D. Staff Scientist

Review of Ingredients Added to Cigarettes

Overview

Kara Lewis, Ph.D.

Staff Scientist

Page 2: Review of Ingredients Added to Cigarettes Overview Kara Lewis, Ph.D. Staff Scientist

Introduction

• Epidemiology shows that cigarette smoking associates with premature human mortality

• Effect of added ingredients is unknown

Page 3: Review of Ingredients Added to Cigarettes Overview Kara Lewis, Ph.D. Staff Scientist

Definition of Added Ingredient

A substance other than tobacco that is added

to a cigarette

Page 4: Review of Ingredients Added to Cigarettes Overview Kara Lewis, Ph.D. Staff Scientist

LSRO Approach

Assess relative risk of adverse health effects

Page 5: Review of Ingredients Added to Cigarettes Overview Kara Lewis, Ph.D. Staff Scientist

Relative Risk

sdx

NS sd

xNS sd

xNS Risk (+)

ingredient Risk (-)ingredient

Page 6: Review of Ingredients Added to Cigarettes Overview Kara Lewis, Ph.D. Staff Scientist

LSRO approachExpert Panel

Carroll E. Cross, M.D.

Division of Pulmonary and Critical Care Medicine

University of California, School of Medicine 

Shayne C. Gad, Ph.D., D.A.B.T.

Gad Consulting Services

Donald E. Gardner, Ph.D., F.A.T.S.

Inhalation Toxicology Associates  

Louis D. Homer, M.D., Ph.D.

Holladay Park Medical Center 

Rudolph J. Jaeger, Ph.D., D.A.B.T.

Environmental Medicine, Inc.

Robert Orth, Ph.D.

Apis Discoveries, LLC.

Resha M. Putzrath, Ph.D., D.A.B.T. (Retired)

Georgetown Risk Group

 Emanuel Rubin, M.D.

Department of Pathology, Anatomy, and Cell Biology

Thomas Jefferson University

 

James L. Schardein, M.Sc., F.A.T.S.

Independent consultant

Thomas J. Slaga, Ph.D.

AMC Cancer Research Center and

Center for Causation and Prevention

Page 7: Review of Ingredients Added to Cigarettes Overview Kara Lewis, Ph.D. Staff Scientist

LSRO Approach

• Convened 11 times to date

• Reviewed more than 3000 publications• Worldwide literature

• Clinical studies

• Government reports

• Books

• Received 21 scientific presentations

Page 8: Review of Ingredients Added to Cigarettes Overview Kara Lewis, Ph.D. Staff Scientist

Project Structure

Phase I: Determination of Feasibility

Phase II: Development of Scientific Criteria

Phase III: Reviews of Individual Ingredients

Page 9: Review of Ingredients Added to Cigarettes Overview Kara Lewis, Ph.D. Staff Scientist

• Determined whether testing ingredients

added to cigarettes is feasible

• Reviewed published literature covering•Smoke chemistry and physics

•Exposure

•Adverse health effects

•Issues and methods in testing

Phase I - Feasibility

Page 10: Review of Ingredients Added to Cigarettes Overview Kara Lewis, Ph.D. Staff Scientist

Phase I - Conclusions

• Testing is feasible and worthwhile.

• Publication of the Phase I report is imminent.

Page 11: Review of Ingredients Added to Cigarettes Overview Kara Lewis, Ph.D. Staff Scientist

Framework to guide the process of testing ingredients added to cigarettes

Phase II – Scientific Criteria

Page 12: Review of Ingredients Added to Cigarettes Overview Kara Lewis, Ph.D. Staff Scientist

Phase III - Reviews of Individual Ingredients

•Use the criteria developed in Phase II

•Process:

–Literature review

–Data analysis

Page 13: Review of Ingredients Added to Cigarettes Overview Kara Lewis, Ph.D. Staff Scientist

• Compare cigarettes with and without added

ingredients

• This approach is feasible

• Phase II is underway

Summary